Your browser doesn't support javascript.
Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK.
Carr, Matthew J; Wright, Alison K; Leelarathna, Lalantha; Thabit, Hood; Milne, Nicola; Kanumilli, Naresh; Ashcroft, Darren M; Rutter, Martin K.
  • Carr MJ; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; NIHR Greater Manchester Patient Safety
  • Wright AK; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of
  • Leelarathna L; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester Univer
  • Thabit H; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester Univer
  • Milne N; Manchester Academic Health Science Centre, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Kanumilli N; Manchester Academic Health Science Centre, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Ashcroft DM; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; NIHR Greater Manchester Patient Safety
  • Rutter MK; Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK; Manchester Academic Health Science Centre, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester Univer
Lancet Diabetes Endocrinol ; 9(7): 413-415, 2021 07.
Article in English | MEDLINE | ID: covidwho-1307280

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article